Literature DB >> 10544012

DNA sequences responsible for reduced promoter activity of human phospholipid transfer protein by fibrate.

A Y Tu1, J J Albers.   

Abstract

Phospholipid transfer protein (PLTP) plays an important role in plasma lipid and lipoprotein metabolism. We have previously cloned and characterized the promoter region of the human PLTP gene. The present study was conducted to determine if the promoter activity of the human PLTP gene is affected by fibrate, a hypolipidemic drug, and to identify DNA sequences that are responsible for the effect. The results indicated that the promoter activity of the PLTP gene was significantly reduced by fenofibrate, and the area that was mainly responsive to the reducing effect by fibrate was located between -377 and -230 of the 5'-flanking region. The DNA sequence analysis suggested that each area of the DNA sequences from -342 to -323 and from -322 to -299 has two repeated sequences, which are inverted and homologous to the recognition motif of peroxisome proliferator-activated receptor (PPAR), namely the PPAR-responsive element (PPRE). Mutagenesis of these PPRE-like sequences, especially that at -322 to -299, abolished most of the reducing effects of fibrate on the PLTP promoter activity. These findings strongly suggest that the PPRE-like elements are responsible for the reduced promoter activity of the human PLTP gene by fibrate. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10544012     DOI: 10.1006/bbrc.1999.1597

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  5 in total

1.  Suppression of ERR targets by a PPARα/Sirt1 complex in the failing heart.

Authors:  Shin-ichi Oka; Peiyong Zhai; Ralph Alcendor; Ji Yeon Park; Bin Tian; Junichi Sadoshima
Journal:  Cell Cycle       Date:  2012-03-01       Impact factor: 4.534

2.  Genetic and nongenetic sources of variation in phospholipid transfer protein activity.

Authors:  Gail P Jarvik; Ramakrishnan Rajagopalan; Elisabeth A Rosenthal; Gertrud Wolfbauer; Laura McKinstry; Aditya Vaze; John Brunzell; Arno G Motulsky; Deborah A Nickerson; Patrick J Heagerty; Ellen M Wijsman; John J Albers
Journal:  J Lipid Res       Date:  2009-11-02       Impact factor: 5.922

3.  Genetic variation in phospholipid transfer protein modulates lipoprotein profiles in hyperalphalipoproteinemia.

Authors:  Mary B Engler; Clive R Pullinger; Mary J Malloy; Yanina Natanzon; Medha V Kulkarni; James Song; Celeste Eng; Jaarko Huuskonen; Christopher Rivera; Annie Poon; Matt Bensley; Amy Sehnert; Christian Zellner; John Kane; Bradley E Aouizerat
Journal:  Metabolism       Date:  2008-12       Impact factor: 8.694

4.  Peroxisome Proliferator Activated Receptor-α Association With Silent Information Regulator 1 Suppresses Cardiac Fatty Acid Metabolism in the Failing Heart.

Authors:  Shin-ichi Oka; Peiyong Zhai; Takanobu Yamamoto; Yoshiyuki Ikeda; Jaemin Byun; Chiao-Po Hsu; Junichi Sadoshima
Journal:  Circ Heart Fail       Date:  2015-10-06       Impact factor: 8.790

5.  Regulation of lipid metabolism-related gene expression in whole blood cells of normo- and dyslipidemic men after fish oil supplementation.

Authors:  Simone Schmidt; Janina Willers; Frank Stahl; Kai-Oliver Mutz; Thomas Scheper; Andreas Hahn; Jan Philipp Schuchardt
Journal:  Lipids Health Dis       Date:  2012-12-14       Impact factor: 3.876

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.